Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Non-Current Assets: 2013-2025

Historic Non-Current Assets for Phibro Animal Health (PAHC) over the last 13 years, with Jun 2025 value amounting to $550.3 million.

  • Phibro Animal Health's Non-Current Assets rose 38.99% to $549.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $549.7 million, marking a year-over-year increase of 38.99%. This contributed to the annual value of $550.3 million for FY2025, which is 44.36% up from last year.
  • Per Phibro Animal Health's latest filing, its Non-Current Assets stood at $550.3 million for FY2025, which was up 44.36% from $381.2 million recorded in FY2024.
  • Over the past 5 years, Phibro Animal Health's Non-Current Assets peaked at $550.3 million during FY2025, and registered a low of $342.4 million during FY2021.
  • Moreover, its 3-year median value for Non-Current Assets was $385.7 million (2023), whereas its average is $439.1 million.
  • In the last 5 years, Phibro Animal Health's Non-Current Assets dropped by 1.16% in 2024 and then surged by 44.36% in 2025.
  • Over the past 5 years, Phibro Animal Health's Non-Current Assets (Yearly) stood at $342.4 million in 2021, then grew by 6.73% to $365.5 million in 2022, then climbed by 5.53% to $385.7 million in 2023, then declined by 1.16% to $381.2 million in 2024, then spiked by 44.36% to $550.3 million in 2025.